[ Pobierz całość w formacie PDF ]

which includes the normal ones. Statistica 46:199 208. Tech 26:331 337.
21. Azzalini A. 2005. The skew-normal distribution and related 42. Poole KR, Taylor RF, Wall GP. 1964. Mixing powders to fine-
multivariate families. Scand J Stat 32:159 188. scale homogeneity: Studies of batch mixing. 24:305 315.
22. Azzalini A, Dalla-Valle A. 1996. The multivariate skew-normal 43. Rubinstein RY, Kroese DP. 2008. Simulation and the Monte
distribution. Biometrika 83:715 726. Carlo method. New Jersey: John Wiley & Son.
23. Arellano-Valle RB, Genton MG. 2005. On fundamental skew 44. Bonate PL. 2001. A brief introduction to Monte Carlo simula-
distributions. J Multivariate Anal 96:93 116. tion. Clin Pharmacokinet 40:15 22.
24. Dey DK, Liu J. 2005. A new construction for skew multivariate 45. Armitage P, Berry G, Matthews JNS. 2001. Statistical methods
distributions. J Multivariate Anal 95:323 344. in medical research. Wiley-Blackwell. p. 292 297.
25. Genton MG, editor. 2004. Skew-elliptical distributions and 46. Press WH, Teukolsky SA, Vetterling T, Flannery BP. 2007.
their applications: A journal beyond normality. Boca Raton, Numerical recipes. Cambridge: Cambridge University Press.
FL, USA: Chapman & Hall/ CRC. 47. Zhang Y, Johnson KC. 1997. Effect of drug particle size on
26. Gupta AK, Chen T. 2001. Goodness-of-fit tests for the skew- content uniformity of low-dose solid dosage forms. Int J Pharm
normal distribution. Commun Stat Simulation Comput 30: 154:179 183.
907 930. 48. Johnson KC. 2009. Chapter 3: Particle size of drug substance
27. Mateu-Figueras G, Puig P, Pewsey A. 2007. Goodness-of-fit and product content uniformity Theoretical considerations.
tests for the skew-normal distribution when the parameters are In: Zheng J, editor. Formulation and analytical development
estimated from the data. Commun Stat Theory Methods 36: for low-dose oral drug products. New Jersey: Wiley. p. 49 62.
1735 1755. 49. European Pharmacopoeia. 2008. 2.9.40. Uniformity of Dosage
28. Pewsey A. 2006. Modeling asymmetrically distributed circular Units. p3325 3327.
data using the wrapped skew-normal distribution. Environ 50. Food and Drug Administration. 2003. Final report on pharma-
Ecol Stats 13:257 269. ceutical cGMPs for 21st century A risk-based approach.
29. Asmussen S. 2003. Applied probability and queues. New York: 51. Yu LX. 2007. Pharmaceutical quality by design: Product and
Springer-Verlag. process development, understanding and control. Pharm Res
30. Walls WD. 2005. Modelling heavy tails and skewness in film 25:781 791.
returns. Appl Financ Econ 15:1181 1188. 52. Lionberger RA, Lee SL, Lee LM, Raw A, Yu LX. 2008. Quality
31. Azzalini A, Dal Cappello T, Kotz S. 2003. Log-skew-normal and by design: Concepts for ANDAs. AAPS J 10:268 276.
log-skew-t distributions as models for family income data. 53. Ku MS. 2008. Use of the biopharmaceutical classification sys-
J Income Distrib 11:12 20. tem in early drug development. AAPS J 10:208 212.
JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 99, NO. 10, OCTOBER 2010 DOI 10.1002/jps [ Pobierz całość w formacie PDF ]